Drugs / Hylo-Comod
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT02817191 | Jun → Nov 2016 | senile cataract | Sun Yat-sen University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03318874 Background | Oct 2017 → Apr 2020 | dry eye syndrome | Oslo University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hylo-Comod | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02817191 ↗ |
| Modality | Other / unclassified | “Tear substitute containing hyaluronic acid, four times daily” NCT03318874 ↗ |
| Route | Other | “The patients were administrated Hylo-Comod eye drop four times a day after Phaco+IOL” NCT02817191 ↗ |